GeneCell International

What GeneCell International does

GeneCell International is a private, for-profit company headquartered in Doral, Florida, that provides processing and cryogenic storage services for child cord blood banking. Its functional role in the value chain is the collection, processing, and long-term storage of hematopoietic stem cells harvested from umbilical cord blood at birth, serving expectant parents and families who elect to privately bank newborn biological material.

The company's product surface is a service offering — physical cryogenic storage backed by laboratory processing — rather than a software or technology product. The underlying operations depend on regulated tissue-handling infrastructure (cryogenic tanks, sterile processing facilities, chain-of-custody protocols) and the relevant regulatory frameworks (FDA, AABB or equivalent accrediting bodies), although the source data does not surface specific certifications, accreditations, or facility details. No proprietary technology, patents, or differentiated processing methods are disclosed.

GeneCell International's business model is presumed to be a hybrid of an upfront processing/enrollment fee plus recurring annual storage fees, consistent with industry-standard cord blood banking economics. Pricing, contract terms, channel mix (direct-to-consumer vs. hospital/OB-GYN referral vs. partnership), and customer acquisition mechanics are not disclosed in the available source material, and the company's primary web property (genecell.com) is currently gated behind a verification/loading checkpoint and does not render substantive commercial content. With 1-10 employees and no disclosed funding, partnerships, or growth signals, the firm operates as a small-scale, privately held service provider.

Name

GeneCell International

Website

https://genecell.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

GeneCell International is a private, Doral, Florida-based service provider that processes and cryogenically stores newborn cord blood for expectant parents and families, operating with 1-10 employees and no disclosed funding or partnerships.

Ownership category

akta.pro rank

Product category

Cord Blood Banking Services

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

Keywords

• Cord blood banking
• Stem cell storage
• Cryogenic preservation
• Cord tissue banking
• Newborn stem cells

Headquarters

HQ city

Doral

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Personnel, Infrastructure, Marketing or Sales, Supply Chain

Core offering

GeneCell International provides processing and cryogenically storing services for a child's cord blood. The company collects, processes, and cryogenically preserves umbilical cord blood and stem cells from newborns for potential future medical use by the donor family. Services are offered to expectant parents on a private/family banking basis.

Differentiator

Problem solved

Functional benefit

Products and services

• Private Cord Blood Banking Collection kit, processing, and long-term cryogenic storage of a newborn's umbilical cord blood stem cells for the donor family, offered to expectant parents as a private/family banking service.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Cord Blood Registry (CBR): One of the largest U.S. family cord blood banks, offering the same core service of umbilical cord blood collection, processing, and cryogenic storage that GeneCell provides.
• ViaCord (Revvity): Family cord blood banking service attached to a large life sciences platform, providing directly competing cord blood and cord tissue collection and cryogenic storage services.
• New England Cord Blood Bank: Regional U.S. cord blood bank that processes and cryogenically stores both family and donor cord blood units, overlapping directly with GeneCell's service model.
• StemCyte: Cord blood bank operating both family storage and public donation programs, competing head-to-head with GeneCell on collection, processing, and long-term storage.
• Cryo-Cell International: Public, Florida-based family cord blood banking company offering processing and long-term cryogenic storage directly comparable to GeneCell's service, including geographically overlapping the South Florida market.
• LifebankUSA: Cord blood and placental stem cell banking service with overlapping collection-and-store model and similar expectant-parent customer base.
• CorCell: Family cord blood banking service focused on collection kits, processing, and cryogenic storage; directly comparable offering and target customer to GeneCell.

Broad incumbents

• BioLife Solutions: Supplier of cryopreservation media, storage solutions, and cold-chain tools used widely across the cell and tissue banking industry, an adjacent incumbent whose products underpin GeneCell's storage operations.

Regional players

• Cells for Life: Canadian family cord blood bank providing the same processing and cryogenic storage service in a different geography, useful as a benchmark for unit economics in the cord blood banking category.
• Future Health Biobank: UK-based stem cell and cord tissue storage bank operating a parallel private banking model across multiple geographies; comparable as a private-pay family banking operator.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights3 records

Customer concentration

• Xx.com/genecellint
• Facebookfacebook.com/genecellinternational
• LinkedInlinkedin.com/company/genecell-international-llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GeneCell International